RxDoctor Payments Data

Lisa Enger

Adult Health · Portland, ORNPI 1295983617

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 53 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Abbott accounts for 76.9% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2024 at $826 and has fallen 75.9% since, to $199 in 2025.

$2,056in general payments, 2019–2025

Across 53 payments — averaging $38.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$2K
  • Boston Scientific$169
  • Abiomed$99
  • Edwards Lifesciences$93
  • Biosense Webster, Inc.$67
  • Impulse Dynamics (USA) Inc.$47

What the payments were for

  • Food & beverage$2,056100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,056 in reported general payments places this provider in the 80th percentile of 96 adult health providers in Oregon.

See all adult health providers in Oregon

Medicare billing

Part B allowed, 2024
$29,768
Medicare patients
187
Services billed
445

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban167$222,630
XareltoRivaroxaban60$78,326
Dofetilide52$10,145
Flecainide Acetate154$7,884
Metoprolol Succinate171$2,512
SotalolSotalol Hcl89$1,790
Diltiazem 24hr Er (La)Diltiazem Hcl11$1,534
Amiodarone Hcl91$1,408
Diltiazem 24hr Er (Cd)Diltiazem Hcl21$485
Metoprolol Tartrate39$282
Warfarin Sodium20$225
Oxycodone Hcl18$114
Atenolol14$100
Carvedilol15$80
Potassium Chloride12$49

Paid to pharmacies, not to this prescriber.

Other adult health in Portland

See the full list for Oregon

Where these figures come from

Is this you, or does something look wrong? →